Sonoma PharmaceuticalsSNOA
13F holders, Q2 2024 (June 30)19holders +3
6new positions
3sold out
1famous investor
$0.21avg. 13F price*
At the end of Q2 2024, 19 institutions reported holding Sonoma Pharmaceuticals Inc. (SNOA) in their 13F filings, up 3 from Q1 2024. 6 opened new positions and 3 sold out. The largest holders were Citadel Advisors ($41K), Geode Capital Management, LLC ($18K) and Jane Street Group, LLC ($10K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Sonoma Pharmaceuticals Inc.
- CUSIP
- 83558L204
- Latest filing quarter
- Q2 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $56K |
| Exits | 3 | $10K |
All 13F filers, Q1 2024 → Q2 2024: 333,601 shares bought and 62,875 shares sold, net +270,726 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 19 holders
| Citadel Advisors | 0.00% | New | 195,157 | $41K |
| Geode Capital Management, LLC | 0.00% | Add +142.2% | 86,644 | $18K |
| Jane Street Group, LLC | 0.00% | New | 45,295 | $10K |
| State Street Corp. | 0.00% | No change | 24,315 | $5K |
| XTX Topco Ltd | 0.00% | Add +20.5% | 19,834 | $4K |
| HRT Financial LP | 0.00% | New | 21,519 | $4K |
| Two Sigma Securities, LLC | 0.00% | Add +13.8% | 15,325 | $3K |
| UBS Group AG | 0.00% | Add +11469.9% | 11,917 | $3K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -31.0% | 8,268 | $2K |
| Qube Research & Technologies Ltd | 0.00% | New | 3,400 | $722 |
| BlackRock Inc. | 0.00% | No change | 2,266 | $481 |
| US Bancorp \de | 0.00% | No change | 500 | $106 |
| Osaic Holdings, Inc. | 0.00% | New | 200 | $42 |
| Bank of America Corp. | 0.00% | Add +290.9% | 172 | $36 |
| Allworth Financial LP | 0.00% | No change | 65 | $21 |
| Morgan Stanley | 0.00% | No change | 86 | $18 |
| Wells Fargo & Company | 0.00% | Reduce -73.0% | 33 | $7 |
| FMR LLC | 0.00% | New | 1 | $0 |
| HBC Financial Services, PLLC | 0.00% | No change | 2 | $0 |
"% of holder's portfolio" is SNOA's weight in each manager's 13F, not the share of Sonoma Pharmaceuticals Inc. the manager owns.